Perform Another (Advanced) Search

1.  CenterWatch: Clinical Trials in Category (108) Obsessive-Compulsive Disorders
...CenterWatch: Clinical Trials in Category (108) Obsessive-Compulsive Disorders Obsessive-Compulsive Disorders State • California • New York California Stanford : Stanford University School of Medicine ...
View Page

2.  Study Posting (799) Trial #153725, Obsessive-Compulsive Disorders, Belmont, MA
...Study Posting (799) Trial #153725, Obsessive-Compulsive Disorders, Belmont, MA Trial Information Brain Function, Structure and Genes in Obsessive Compulsive Disorder Children ...
View Page

3.  Study Posting (2348) Trial #50072, Obsessive-Compulsive Disorders, New York, NY
...Study Posting (2348) Trial #50072, Obsessive-Compulsive Disorders, New York, NY Trial Information Ziprasidone augmentation in serotonin reuptake inhibitor-resistant Obsessive-Compulsive ...
View Page

4.  Study Posting (799) Trial #154724, Obsessive-Compulsive Disorders, Boston, MA
...Study Posting (799) Trial #154724, Obsessive-Compulsive Disorders, Boston, MA Trial Information Spatiotemporal dynamics of contextual processing in schizophrenia, autism spectrum disorder ...
View Page

5.  Study Posting (709) Trial #116325, Obsessive-Compulsive Disorders, Stanford, CA
...Study Posting (709) Trial #116325, Obsessive-Compulsive Disorders, Stanford, CA Trial Information The purpose of this study is to determine whether memantine ...
View Page

6.  Study Posting (77) Trial #155209, Obsessive-Compulsive Disorders, New Hyde Park, NY
...Study Posting (77) Trial #155209, Obsessive-Compulsive Disorders, New Hyde Park, NY Trial Information Chronic Obstructive Pulmonary Disease- Adults Adults with Chronic ...
View Page

7.  Newly Approved Drug Therapies (319) Zoloft (sertraline HCl), Pfizer,
...Name: Zoloft (sertraline HCl) Company: Pfizer Approval Status: Approved October 1997 Treatment Area: panic disorder/obsessive compulsive disorder General Information The U.S. Food and Drug Administration (FDA) approved Zoloft for the ...
View Page

8.  Study Posting (799) Trial #159822, *Healthy Patient Studies, Boston, MA
...Boston, MA Trial Information Spatiotemporal dynamics of contextual processing in schizophrenia, autism spectrum disorder, and obsessive-compulsive disorder Eligibility: We are looking for healthy male volunteers between the ages of 35 and ...
View Page

9.  Study Posting (799) Trial #156510, Autism, Boston, MA
...Boston, MA Trial Information Spatiotemporal dynamics of contextual processing in schizophrenia, autism spectrum disorder, and obsessive-compulsive disorder • Principal Investigator Dara S. Manoach, Ph.D. Department of Psychiatry - Massachusetts General Hospital and ...
View Page

10.  Study Posting (799) Trial #159826, Schizophrenia and Schizoaffective Disorders, Boston, MA
...Boston, MA Trial Information Spatiotemporal dynamics of contextual processing in schizophrenia, autism spectrum disorder, and obsessive-compulsive disorder • Principal Investigator Dara S. Manoach, Ph.D. Department of Psychiatry - Massachusetts General Hospital and ...
View Page

11.  Study Posting (799) Trial #156518, Schizophrenia and Schizoaffective Disorders, Boston, MA
...Boston, MA Trial Information Spatiotemporal dynamics of contextual processing in schizophrenia, autism spectrum disorder, and obsessive-compulsive disorder • Principal Investigator Dara S. Manoach, Ph.D. Department of Psychiatry - Massachusetts General Hospital and ...
View Page

12.  Newly Approved Drug Therapies (254) LUVOX (fluvoxamine maleate), Solvay Pharmaceuticals, Pharmacia & Upjohn,
...LUVOX (fluvoxamine maleate) Company: Solvay Pharmaceuticals, Pharmacia & Upjohn Approval Status: Approved April 1997 Treatment Area: obsessive compulsive disorder General Information LUVOX (fluvoxamine maleate) has been approved for the treatment of obsessive compulsive ...
View Page

13.  Newly Approved Drug Therapies (104) Paxil (paroxetine hydrochloride), SmithKline Beecham,
...Paxil (paroxetine hydrochloride) Company: SmithKline Beecham Approval Status: Approved May 1996 Treatment Area: panic disorder, obsessive-compulsive disorders General Information Paxil has been approved for the treatment of panic disorder, a disabling ...
View Page

14.  CenterWatch Clinical Research Profile (1685) Trial #861, Pharmasite Research, Inc., Baltimore, MD
...disorders in the child, adult and geriatric populations. Key therapeutic interests include depression, bipolar disorder, obsessive-compulsive disorder, anxiety, cognitive problems in early to moderate dementia and behavioral problems associated with dementia ...
View Page

15.  Study Posting (77) Trial #154290, Depression (Major/Severe), Bronx, NY
...in this study if you: • Have a history of depressive episode with psychotic features • Have obsessive compulsive disorder • Suffer from bulimia or anorexia nervosa • Have a history of mental retardation, delirium, dementia ...
View Page

16.  Study Posting (5306) Trial #154158, Depression (Adolescent), Riverside, CA
...a current diagnosis of bipolar disorder, psychotic depression, schizophrenia or other psychotic disorder, anorexia, bulimia, obsessive compulsive disorder, or pervasive development disorder. • Have history of DSM-IV-TR defined substance abuse or ...
View Page

17.  Study Posting (961) Trial #134397, Bipolar Disorders, Clementon, NJ
...65 Patient Exclusion Criteria: • a history of attention-deficit/hyperactivity disorder (ADHD), eating disorder or obsessive compulsive disorder (OCD) • patient has a past or present seizure disorder, head trauma that is clincally ...
View Page

18.  Study Posting (2348) Trial #50073, Binge Eating Disorder, New York, NY
...adolescents. Sertraline is approved by the Food and Drug Administration (FDA) for the treatment of obsessive-compulsive disorder (OCD) and depression, but not approved for the treatment of BED. Study volunteers will ...
View Page

19.  CenterWatch Clinical Research Profile (430) Trial #1304, Radiant Research - Denver, Denver, CO
...Disorder (GAD) • Headache/Migraine • Herpes – Labialis • Hyperlipidemia • Hypertension • Male Sexual Dysfunction • Mild Cognitive Impairment • Obesity • Obsessive Compulsive Disorder • Osteoarthritis • Osteoporosis • Pain – Acute and Chronic • Panic Disorder • Post Traumatic Stress Disorder • Restless leg ...
View Page

20.  Newly Approved Drug Therapies (292) Zoloft (sertraline HCl), Pfizer,
...depression. Zoloft was introduced for the treatment of depression in 1992 and, in 1996, for obsessive-compulsive disorder. The new clearance specifies that Zoloft may be marketed for the treatment of panic ...
View Page